Pasithea Therapeutics Corp. (KTTA) Earnings Signals & AI Vibe Check
Cross-checked across multiple AI analysts and grounded in the latest SEC filing.
powered by: earningsVibe.ai
Question:
What is the latest filing signal for Pasithea Therapeutics Corp.?
Answer:
Based on earningsVibe SuperAnalyst™ synthesis of the latest
10-K, Pasithea Therapeutics Corp.'s filing signal
turned positive.
earningsVibe SuperAnalyst™ Verdict:
TURNED POSITIVE
Signal Performance — Stock Price Since Filing
30-Day Change
Pending
from filing date
60-Day Change
Pending
from filing date
Underlying analyst views from Perplexity, Gemini, Claude, and ChatGPT
PERPLEXITY
Continuing Negative
GEMINI
Turned Positive
CLAUDE
Turned Positive
CHATGPT
Turned Negative
Unlock the Full Filing Analysis
See full earningsSig™ and risksSig™ analysis across 5,000+ companies
Get Started Free →No credit card required
Question:
What does Pasithea Therapeutics Corp. actually do?
Answer:
Pasithea Therapeutics Corp. is a clinical-stage biotechnology company focused on developing novel treatments for RASopathies, MAPK pathway-driven tumors, and central nervous system disorders. Its lead product candidate, PAS-004, is a next-generation macrocyclic MEK inhibitor designed to improve upon existing MEK inhibitors by offering enhanced selectivity, oral bioavailability, and metabolic stability. PAS-004 is currently in Phase 1/1b clinical trials for neurofibromatosis type 1 (NF1) plexiform neurofibromas (NF1-PN) and advanced solid tumors with MAPK pathway alterations. The company also has a discovery-stage program, PAS-001, targeting C4A for schizophrenia. Pasithea Therapeutics aims to address significant unmet medical needs in these disease areas.
Question:
What are Pasithea Therapeutics Corp.'s revenue drivers?
Answer:
The company's revenue drivers are currently limited to potential future product sales, as it is in the clinical development stage and has not yet commercialized any products.
Cut through noisy SEC filings to find the signal faster
Source-grounded filing intelligence with one-click links back to the filing, so you can move faster and verify everything at the source.
Get Started Free →No credit card required